Managing Patients with Chronic Non-Terminal Pain [2015 revision]
To begin this activity, click Enroll. Once logged in, learners can access educational content, assessments, and evaluations. Learners who successfully complete the activity will be able to print a certificate.
The purpose of this clinical guideline is to support clinicians in evaluating and managing patients with chronic pain. Topics addressed include:
- Using multi-dimensional approaches for evaluation and treatment
- Setting treatment goals that focus on realistic improvement of functioning
- Utilizing non-pharmacologic therapies
- Managing any associated mood and psychiatric disorders
- Selecting medications based on presumed pain type and comorbidities
- Regular follow-up on patients
- Special issues with opioids:
- Assessing patients for dependence and addiction risk
- Selection and use of opioids
- Structuring ongoing opioid therapy to recognize and address addiction and diversion
Appended to the guideline are several tools to assist the clinician in evaluating chronic pain and in structuring the management of ongoing use of opioids.
The University of Michigan Medical School designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Release Date: March 2009
Termination Date: May 2020
[If the activity has been reviewed and credit has been extended, this statement should appear below the Accreditation & Credit designation statements on the web page]
Continued availability of CME credit for this activity depends on a thorough review of its content every three years. This activity was last reviewed for currency and accuracy in June 2017, and availability of CME credit continued.
Daniel W Berland, MD; General Medicine / Anesthesiology
Phillip E Rodgers, MD; Family Medicine
Carmen R Green, MD; Anesthesiology
R Van Harrison, PhD; Medical Education
Randy S Roth, PhD; Physical Medicine & Rehabilitation
Daniel J. Clauw, MD; Rheumatology
Jennifer A. Meddings, MD; General Medicine
Ronald A Wasserman, MD; Anesthesiology
Financial Disclosure Information:
Daniel J. Clauw, MD
Consultant: Cypress Bio-sciences, Forest, Lilly, Pfizer, Pierre Fabre, Takeda, UCB
Research Funding: Cypress Bio-sciences, Forest
There are no other relevant financial relationships to disclose for this CME activity.
UMHS Guidelines Oversight Team:
Grant Greenberg, MD, MA, MHSA
R. Van Harrison, PhD
Literature Search Services:
Taubman Medical Library